Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 59
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text

RECORDATI RARE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 61
  • 0 comments

FDA approve OSILODROSTAT PHOSPHATE

Comment Full text

SUNSHINE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 51
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 64
  • 0 comments

FDA approve RANOLAZINE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 61
  • 0 comments

FDA approve CARBIDOPA; ENTACAPONE; LEVODOPA

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 67
  • 0 comments

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

MYLAN

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 41
  • 0 comments

FDA approve ALMOTRIPTAN MALATE

Comment Full text

MSN

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 53
  • 0 comments

FDA approve RUFINAMIDE

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 63
  • 0 comments

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 53
  • 0 comments

FDA approve ABACAVIR SULFATE; LAMIVUDINE

Comment Full text
  • Previous
  • 197
  • 198
  • 199
  • 200
  • 201
  • Next

Search

News categories

  • Technical Exchange News(12263)
  • Event(6229)
  • SEC News(267570)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155701)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin